- Info
- Insider Trading
- Financials
- Holders: ENGN, ENGNW
enGene Holdings Inc. - *W EXP 10/31/202 (ENGNW)
CUSIP: 29286M113
Q4 2023 13F Holders as of 31 Dec 2023
- Type / Class
- Equity / *W EXP 10/31/202
- Total 13F shares
- 4,440,160
- Share change
- +3,965,084
- Total reported value
- $3,691,565
- Price per share
- $0.85
- Number of holders
- 21
- Value change
- +$3,287,750
- Number of buys
- 20
Quarterly Holders Quick Answers
What is CUSIP 29286M113?
CUSIP 29286M113 identifies ENGNW - enGene Holdings Inc. - *W EXP 10/31/202 in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q1 2024
Recent filing periods for CUSIP 29286M113:
Top shareholders of ENGNW - enGene Holdings Inc. - *W EXP 10/31/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Forbion Growth Sponsor FEAC I B.V. |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
5,502,338
mixed-class rows
|
— | — | 31 Oct 2023 | |
| Forbion Capital Fund III Cooperatief U.A. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,894,735
|
— | — | 31 Oct 2023 | |
| Jason David Hanson |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
512,826
|
— | — | 31 Oct 2023 | |
| Richard P. Bryce |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
153,000
|
— | — | 30 Nov 2023 | |
| James C. Sullivan |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
118,509
|
— | — | 31 Oct 2023 | |
| BVF PARTNERS L P/IL |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
104,257
|
— | — | 31 Oct 2023 |
Institutional Holders of enGene Holdings Inc. - *W EXP 10/31/202 (ENGNW) as of Q4 2023
As of 31 Dec 2023,
enGene Holdings Inc. - *W EXP 10/31/202 (ENGNW) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,440,160 shares.
The largest 10 holders included
BVF INC/IL, HIGHBRIDGE CAPITAL MANAGEMENT LLC, Omega Fund Management, LLC, Blue Owl Capital Holdings LP, FCPM III SERVICES B.V., Calamos Advisors LLC, COWEN AND COMPANY, LLC, AQR Arbitrage LLC, TENOR CAPITAL MANAGEMENT Co., L.P., and D. E. Shaw & Co., Inc..
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2023 vs Q3 2025 Across Filers
Q3 2025 holders
17
Q4 2023 holders
21
Holder diff
4
| Investor | Q3 2025 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.